U.S. flag

An official website of the United States government

NM_001204.7(BMPR2):c.1141dup (p.Arg381fs) AND Primary pulmonary hypertension

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Aug 23, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001388597.7

Allele description [Variation Report for NM_001204.7(BMPR2):c.1141dup (p.Arg381fs)]

NM_001204.7(BMPR2):c.1141dup (p.Arg381fs)

Gene:
BMPR2:bone morphogenetic protein receptor type 2 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
2q33.2
Genomic location:
Preferred name:
NM_001204.7(BMPR2):c.1141dup (p.Arg381fs)
HGVS:
  • NC_000002.12:g.202532597dup
  • NG_009363.1:g.161271dup
  • NM_001204.7:c.1141dupMANE SELECT
  • NP_001195.2:p.Arg381fs
  • LRG_712t1:c.1141dup
  • LRG_712:g.161271dup
  • LRG_712p1:p.R381Kfs*18
  • NC_000002.11:g.203397319_203397320insA
  • NC_000002.11:g.203397320dup
  • NM_001204.6:c.1141dupA
  • NP_001195.2:p.R381Kfs*18
Protein change:
R381fs
Links:
dbSNP: rs1085307303
NCBI 1000 Genomes Browser:
rs1085307303
Molecular consequence:
  • NM_001204.7:c.1141dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Primary pulmonary hypertension (PPH1)
Identifiers:
MONDO: MONDO:0001999; MedGen: C0152171

Recent activity

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001589651Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Aug 23, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele.

Hamid R, Cogan JD, Hedges LK, Austin E, Phillips JA 3rd, Newman JH, Loyd JE.

Hum Mutat. 2009 Apr;30(4):649-54. doi: 10.1002/humu.20922.

PubMed [citation]
PMID:
19206171
PMCID:
PMC2663001

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

Machado RD, Aldred MA, James V, Harrison RE, Patel B, Schwalbe EC, Gruenig E, Janssen B, Koehler R, Seeger W, Eickelberg O, Olschewski H, Elliott CG, Glissmeyer E, Carlquist J, Kim M, Torbicki A, Fijalkowska A, Szewczyk G, Parma J, Abramowicz MJ, Galie N, et al.

Hum Mutat. 2006 Feb;27(2):121-32.

PubMed [citation]
PMID:
16429395
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001589651.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Arg381Lysfs*18) in the BMPR2 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with pulmonary arterial hypertension (PMID: 19206171). ClinVar contains an entry for this variant (Variation ID: 425880). Loss-of-function variants in BMPR2 are known to be pathogenic (PMID: 16429395). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024